Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameRMH Holdings
Stock Code08437
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們為獲新加坡衛生部正式認可的領先皮膚及外科專科診所,專門針對影響皮膚、頭髮及指甲的各種皮膚問題,採用一系列先進完善的醫療、外科、激光及美容療程,提供方便全面而優質的專業護理服務。主要提供諮詢服務、處方及配藥服務、療程服務(外科療程、微創/無創療程)及其他服務。
Listing Date2017-10-13
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港皇后大道中183號中遠大廈9樓911室
Business Address (Hong Kong)香港皇后大道中99號中環中心57樓5705室
Place of Incorporation開曼群島
Listing Method發售以供認購 + 發售以供配售
Listing BoardGEM
Websitedermclinic.com.sg
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 0.48 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2017-09-29 to 2017-10-06
Global Offering Shares150,000,000 shares
HK Public Offer Shares (Initial)15,000,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)135,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO600,000,000 shares
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 72,000,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 17.3M
Est. Threshold HK$ 9.73B
Analysis Result HK market cap below threshold, need +56282%

Valuation & Financials

Market Cap (at Offer Price)HK$ 288,000,000
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約2.681百萬新加坡元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201520162017-03
Revenue 5,5966,1601,609
Other income and gains, net 3316819
Net finance costs -7-8-2
Profit before tax 2,5793,044237
Income tax expense -328-363-43
Profit for the year 2,2512,681194
Profit attributable to owners 2,2512,681194
Balance Sheet
Item 201520162017-03
Cash and cash equivalents 8164781,665
Trade and bills receivables 350612815
Inventories 158149171
Total current assets 1,3241,2392,651
Total current liabilities 8731,0502,240
Total equity 764436630
Equity attributable to owners 764436630
Interest-bearing borrowings 392281253
Cash Flow Statement
Item 201520162017-03
Net cash from operating activities 3,1942,838312
Net cash from investing activities -124-480
Net cash from financing activities -3,012-3,128875
Net increase in cash 58-3381,187
Depreciation of PP&E 21522156
Purchase of PP&E -124-480
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 0.68
First Day OpenHK$ 0.57
First Day Change41.67%
First Day Volume138120000.0
First Day Turnover80706800.0
Use of Proceeds
1、約14.7百萬港元或約31.6%將用作策略性地擴展及加強本集團在新加坡的診所網絡; 2、約14.1百萬港元或約30.4%將用作提升本集團現有診所的質素及服務種類及成立新醫學美容診所; 3、約9.9百萬港元或約21.4%將用作購買額外新器材并擴大所提供療程、程序及產品種類; 4、約2.4百萬港元或約5.1%將用作建立中央運作的物流中心; 5、約2.5百萬港元或約5.4%將用作改善本集團的信息科技基礎設施及系統; 6、約2.8百萬港元或約6.1%將用作本集團的一般營運資金。

Underwriting Syndicate

Sole Sponsor (1)
LY CAPITAL LIMITED CE BBT182
Joint Bookrunners (1)
GAOYU SECURITIES LIMITED CE AAE696
Joint Lead Managers (1)
GAOYU SECURITIES LIMITED CE AAE696

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
ChairmanLoh Teck Hiong—
Company Secretary文潤華—
No director data available.

Major Shareholders

Major Shareholders & HoldingsBrisk Success持有405,000,000股,佔67.5%;Loh醫生、Ee醫生及柯醫生各自透過Brisk Success被視為擁有權益,各佔67.5%;妙濤持有45,000,000股,佔7.5%;王醫生透過妙濤擁有權益;黄藹怡女士配偶權益佔7.5%。
About this page

This page shows RMH Holdings (08437) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect